MedTrace Logo

Serranator® Alto Post Market Clinical Follow Up (PMCF) Study

NCT03538392 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-04-10

No results posted yet for this study

Summary

The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® Alto in treatment of peripheral artery disease (PAD), or dysfunctional native or synthetic arteriovenous dialysis fistulae in a real-world scenario.

Conditions

  • Peripheral Arterial Disease
  • Arterio-venous Fistula
  • Arteriovenous Graft

Interventions

DEVICE

Serranator® Alto

Serranator® Alto PTA Serration Balloon Catheter

Sponsors & Collaborators

  • Cagent Vascular LLC

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2019-12-31
Completion
2019-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03538392 on ClinicalTrials.gov